These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82. A detailed description of the phenotypic spectrum of North Sea Progressive Myoclonus Epilepsy in a large cohort of seventeen patients. Polet SS; Anderson DG; Koens LH; van Egmond ME; Drost G; Brusse E; Willemsen MA; Sival DA; Brouwer OF; Kremer HP; de Vries JJ; Tijssen MA; de Koning TJ Parkinsonism Relat Disord; 2020 Mar; 72():44-48. PubMed ID: 32105965 [TBL] [Abstract][Full Text] [Related]
84. 'North Sea' progressive myoclonus epilepsy: phenotype of subjects with GOSR2 mutation. Boissé Lomax L; Bayly MA; Hjalgrim H; Møller RS; Vlaar AM; Aaberg KM; Marquardt I; Gandolfo LC; Willemsen M; Kamsteeg EJ; O'Sullivan JD; Korenke GC; Bloem BR; de Coo IF; Verhagen JM; Said I; Prescott T; Stray-Pedersen A; Rasmussen M; Vears DF; Lehesjoki AE; Corbett MA; Bahlo M; Gecz J; Dibbens LM; Berkovic SF Brain; 2013 Apr; 136(Pt 4):1146-54. PubMed ID: 23449775 [TBL] [Abstract][Full Text] [Related]
85. Unverricht-Lundborg disease with cystatin B gene abnormalities. Kagitani-Shimono K; Imai K; Okamoto N; Ono J; Okada S Pediatr Neurol; 2002 Jan; 26(1):55-60. PubMed ID: 11814737 [TBL] [Abstract][Full Text] [Related]
86. Cathepsin B but not cathepsins L or S contributes to the pathogenesis of Unverricht-Lundborg progressive myoclonus epilepsy (EPM1). Houseweart MK; Pennacchio LA; Vilaythong A; Peters C; Noebels JL; Myers RM J Neurobiol; 2003 Sep; 56(4):315-27. PubMed ID: 12918016 [TBL] [Abstract][Full Text] [Related]
88. Mutation of SCARB2 in a patient with progressive myoclonus epilepsy and demyelinating peripheral neuropathy. Dibbens LM; Karakis I; Bayly MA; Costello DJ; Cole AJ; Berkovic SF Arch Neurol; 2011 Jun; 68(6):812-3. PubMed ID: 21670406 [TBL] [Abstract][Full Text] [Related]
89. Utility of Skin Biopsy in a Case of Progressive Myoclonic Epilepsy: Challenge. Frantz T; Fortson E; Strowd LC Am J Dermatopathol; 2018 Sep; 40(9):e123. PubMed ID: 28692462 [No Abstract] [Full Text] [Related]
90. A new SCARB2 mutation in a patient with progressive myoclonus ataxia without renal failure. Perandones C; Pellene LA; Micheli F Mov Disord; 2014 Jan; 29(1):158-9. PubMed ID: 24339182 [No Abstract] [Full Text] [Related]
91. Teenage-onset progressive myoclonic epilepsy due to a familial van den Ameele J; Jedlickova I; Pristoupilova A; Sieben A; Van Mossevelde S; Ceuterick-de Groote C; Hůlková H; Matej R; Meurs A; Van Broeckhoven C; Berkovic SF; Santens P; Kmoch S; Dermaut B Neurology; 2018 Feb; 90(8):e658-e663. PubMed ID: 29352102 [TBL] [Abstract][Full Text] [Related]
98. Perampanel in 12 patients with Unverricht-Lundborg disease. Crespel A; Gelisse P; Tang NP; Genton P Epilepsia; 2017 Apr; 58(4):543-547. PubMed ID: 28166365 [TBL] [Abstract][Full Text] [Related]
99. A patient with 2 different repeat expansion mutations. Nokelainen P; Heiskala H; Lehesjoki AE; Kaski M Arch Neurol; 2000 Aug; 57(8):1199-203. PubMed ID: 10927802 [TBL] [Abstract][Full Text] [Related]
100. Progressive myoclonic epilepsies: it takes a village to make a diagnosis. Knupp K; Wirrell E Neurology; 2014 Feb; 82(5):378-9. PubMed ID: 24384640 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]